Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic

Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic

Authors

  • Dr. Viral Shah Assistant Professor, Department Of Pulmonary Medicine, SVP Hospital, Ahmedabad
  • Dr. Mehul Gajjar Associate Professor, Emergency Medicine, SVP Hospital, Ahmedabad
  • Dr. Sanjay Tripathi Professor And Head, Department Of Pulmonary Medicine, SVP Hospital, Ahmedabad

Keywords:

High Flow Nasal Cannula Therapy, Acute Respiratory Failure, Co-Morbidities

Abstract

Background: High flow nasal cannula is a newer modality of treatment for hypoxemic respiratory failure. Present study is conducted to evaluate demographic characteristics, co-morbidities and outcome parameters of patients on High flow nasal cannula. Material And Methods: In retrospective observational study all patients on High flow nasal canula with covid-19 were evaluated for demographic characteristics and outcome with comorbidities during study period. Result: Maximum number of patients belongs to age group 51-60 years. Highest mortality was in the age group of 61-70 years. Conclusion: The High flow nasal cannula therapy may provide important newer modality and helpful in patients with respiratory failure. [Shah V Natl J Integr Res Med, 2022; 13(1): 61-63, Published on 26/01/2022]

Downloads

Published

2022-01-26

How to Cite

Dr. Viral Shah, Dr. Mehul Gajjar, & Dr. Sanjay Tripathi. (2022). Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic: Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic. National Journal of Integrated Research in Medicine, 13(1), 61–63. Retrieved from http://nicpd.ac.in/ojs-/index.php/njirm/article/view/3401

Issue

Vol. 13 No. 1 (2022): NJIRM

Section

Original Articles